|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/24/20 Surgery Partners, Inc. 8-K:8,9 7/23/20 2:28K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 15K 2: EX-99.1 Miscellaneous Exhibit HTML 8K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
| Date of Report (Date of earliest event reported): July 23, 2020 | ||
| Surgery Partners, Inc. | ||
| (Exact Name of Registrant as Specified in Charter) | ||
| Delaware | 001-37576 | 47-3620923 |
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
310 Seven Springs Way, Suite 500 | ||
| (Address of Principal Executive Offices) (Zip Code) | ||
| (615) 234-5900 | ||
| (Registrant's Telephone Number, Including Area Code) | ||
| Not Applicable | ||
| (Former Name or Former Address, If Changed Since Last Report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) |
Name of each exchange on which registered | ||
| Common stock, par value $0.01 per share | SGRY | The Nasdaq Global Select Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 8.01 | Other Events. |
On July 23, 2020, Surgery Center Holdings, Inc. (the “Issuer”), entered into a purchase agreement with Jefferies LLC as representative of certain initial purchasers, relating to the issuance and sale of $115.0 million in aggregate principal amount of the Issuer’s 10.000% senior unsecured notes due 2027 (the “Offering”). The net proceeds from the Offering will be used for general corporate purposes and to fund growth-related activities, including, but not limited to, service line expansions, physician recruiting and technology infrastructure investments and potential acquisitions. The consummation of the Offering is subject to market and other conditions.
On July 23, 2020, Surgery Partners, Inc. issued a press release announcing the pricing of the notes offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
| Exhibit No. |
Description | |
| 99.1 | Press release dated July 23, 2020 |
C:
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: July 23, 2020 | SURGERY PARTNERS, INC. | |
| By: | /s/ Thomas F. Cowhey | |
| Name: Thomas F. Cowhey | ||
| Title: Executive Vice President and Chief Financial Officer | ||
C:
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 7/24/20 | None on these Dates | ||
| For Period end: | 7/23/20 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/18/23 Surgery Partners, Inc. 424B7 2:392K Toppan Merrill/FA 12/14/23 Surgery Partners, Inc. 424B7 1:373K Toppan Merrill/FA 11/22/22 Surgery Partners, Inc. 424B5 2:678K Toppan Merrill/FA 11/21/22 Surgery Partners, Inc. 424B5 1:630K Toppan Merrill/FA 11/10/21 Surgery Partners, Inc. 424B5 1:669K Toppan Merrill/FA 11/08/21 Surgery Partners, Inc. 424B5 1:660K Toppan Merrill/FA 1/29/21 Surgery Partners, Inc. 424B5 1:770K Toppan Merrill/FA 1/26/21 Surgery Partners, Inc. 424B5 1:762K Toppan Merrill/FA 1/25/21 Surgery Partners, Inc. S-3ASR 1/25/21 4:293K Toppan Merrill/FA |